Particle.news
Download on the App Store

CDC Vaccine Panel Delays Hepatitis B Birth-Dose Vote, Reconvenes Today

Revised proposals would replace the universal newborn shot with risk-based guidance centered on parental decision-making.

Overview

  • After a chaotic session marked by last-minute wording changes, ACIP voted 6–3 to postpone Thursday’s decision and return Friday to consider reworked motions.
  • Draft language would keep an automatic birth dose for infants of mothers who test positive and reaffirm it when status is unknown, while suggesting shared decision-making with a possible delay to at least two months for infants of mothers who test negative.
  • Public-health experts and more than 30 Democratic lawmakers urged maintaining the universal birth dose, citing decades of safety monitoring, a 99% drop in pediatric hepatitis B since 1991, and modeling that predicts roughly 1,400 additional infections annually if the dose is delayed to two months.
  • Any rollback could disrupt coverage and access because federal programs such as Vaccines for Children and many private insurers tie benefits to ACIP recommendations, potentially complicating birth-dose availability in hospitals.
  • The meeting underscored concerns about process and politicization after RFK Jr. replaced prior members, with vaccine-critical testimony and stigmatizing claims about immigrants and gay men drawing criticism from physicians and former CDC leaders.